Next Article in Journal
Li–Fraumeni Syndrome: Mutation of TP53 Is a Biomarker of Hereditary Predisposition to Tumor: New Insights and Advances in the Treatment
Previous Article in Journal
The Differential Metabolic Signature of Breast Cancer Cellular Response to Olaparib Treatment
 
 
Review

Article Versions Notes

Cancers 2022, 14(15), 3662; https://doi.org/10.3390/cancers14153662
Action Date Notes Link
article pdf uploaded. 27 July 2022 16:10 CEST Version of Record https://www.mdpi.com/2072-6694/14/15/3662/pdf-vor
article xml file uploaded 28 July 2022 11:16 CEST Original file -
article xml uploaded. 28 July 2022 11:16 CEST Update https://www.mdpi.com/2072-6694/14/15/3662/xml
article pdf uploaded. 28 July 2022 11:16 CEST Updated version of record https://www.mdpi.com/2072-6694/14/15/3662/pdf
article html file updated 28 July 2022 11:18 CEST Original file -
article html file updated 13 August 2022 04:07 CEST Update https://www.mdpi.com/2072-6694/14/15/3662/html
Back to TopTop